Clinical Trial

GEKO Venous Thromboembolism Prevention Study

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 4, 2025 (before its estimated April 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This multicentre, randomised geko™ venous thromboembolism (VTE) prevention study will prospectively collect clinical data on VTE occurrences in immobile patients after stroke, who will be randomised, on a 1:1 allocation, to receive either standard of care (Intermittent Pneumatic Compression) or geko™ neuromuscular electrostimulation device. The aim is to assess the prevention of VTE during a follow-up period of 90 days (three months) post-randomisation.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-07-25; most recent amendment 2025-02-27.
Status change: Not Yet Recruiting → Recruiting 2023-07-06
Trial Details
NCT Number NCT05476913
Lead Sponsor Firstkind Ltd
Collaborators: National Institute for Health Research, United Kingdom, Keele University, University Hospitals of North Midlands NHS Trust, University of California, Bournemouth University
Conditions Stroke, Acute, Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism
Enrollment 1,200 participants
Start Date 2023-07-06
Primary Completion 2025-04-30 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-04